Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Luxembourg is currently experiencing certain trends and developments that are shaping its growth trajectory.
Customer preferences: Luxembourg has a high vaccination rate, with a significant portion of the population opting for vaccines. The country's healthcare system is robust and well-equipped to handle the demand for vaccines, with a focus on ensuring that all citizens have access to them.
Trends in the market: The Other Vaccines market in Luxembourg is growing steadily, driven by an increase in demand for vaccines that offer protection against various diseases. The market is also benefiting from advancements in vaccine technology, which are making vaccines more effective and safer. Additionally, the COVID-19 pandemic has highlighted the importance of vaccines, leading to increased awareness and demand for them.
Local special circumstances: Luxembourg is a small country with a high population density, which makes it easier for diseases to spread. Therefore, there is a greater need for vaccines to prevent the spread of communicable diseases. Additionally, the country has a large expat population, which means that there is a need for vaccines that protect against diseases that are prevalent in other parts of the world.
Underlying macroeconomic factors: Luxembourg has a strong economy, with a high per capita income and a well-educated population. This has contributed to a high demand for quality healthcare services, including vaccines. Additionally, the country is home to several pharmaceutical companies that are involved in the development and production of vaccines. These companies are driving innovation in the sector and contributing to the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
